STAT1 and infection: Investigation of the ability of anti-CLEC5A mAb to protect Stat1−/− mice from JEV-induced lethality revealed that 50% of Stat1−/− mice that succumbed to JEV infection died in the early stages (6 days post infection), and all the mice died within 9 days post infection.